Mark Anthony Murray serves as Executive at Oyster Point Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Mark Anthony Murray has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 3, 2023 involved selling 3,573 shares valued at $0.
Mark Anthony Murray currently holds 3,573 shares of Oyster Point Pharma, Inc. (OYST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Anthony Murray has been a net neutral trader of OYST stock. They have purchased $0 and sold $0 worth of shares.
Mark Anthony Murray's most recent insider trade was on Jan 3, 2023, when they sold 3,573 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 6, 2022 | OYST | $0 | Award | 3,573 | $N/A | Discretionary |
| Jun 7, 2021 | OYST | $0 | Award | 3,466 | $N/A | Discretionary |
| Jun 8, 2020 | OYST | $0 | Award | 6,600 | $N/A | Discretionary |
| Nov 4, 2019 | OYST | $0 | Conversion | 106,517 | $N/A | Discretionary |